STESTERIS plc
$214.44-14% 1Y
$214.44
$199.4052 weeks$267.17
The financials
STERIS plc by the numbers
STERIS plc (STE) reported revenue of $1.49B in Q1 2027 (quarter ended Jun 30, 2026), up 7.3% from the same quarter a year earlier. That came with a gross margin of 46% and net income of $200M (13% of revenue). For the full year FY2026, revenue was $5.94B (+8.7% year on year) and net income $782M. Its largest segment in Q1 2027 was Healthcare at $1.05B, 70% of the disclosed total, well ahead of Applied Sterilization Technologies at 20%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
| Income statement | Q1 2027 | Q1 2026 | Change |
|---|---|---|---|
| Revenue | $1.49B | $1.39B | +7.3% |
| Gross profit | $684M | $628M | +8.9% |
| Operating income | $286M | $246M | +16% |
| Net income | $200M | $177M | +13% |
| Diluted EPS | $2.04 | $1.79 | +14% |
| Operating | Revenue | Share |
|---|---|---|
| Healthcare | $1.05B | 70% |
| Applied Sterilization Technologies | $298M | 20% |
| Life Science | $147M | 9.8% |
Business segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Jun 2026Total $1.49B (+416%)
Life Science grew +8.5% year on yearApplied Sterilization Technologies +5.8% year on year
Segment Latestquarter on quarteryear on year
- Healthcare$1.05B$1.05Bquarter on quarter n/ayear on year +7.6%n/a+7.6%
- Applied Sterilization Technologies$297.6M$297.6Mquarter on quarter +2.9%year on year +5.8%+2.9%+5.8%
- Life Science$146.7M$146.7Mquarter on quarter n/ayear on year +8.5%n/a+8.5%